TREM2 and early-onset autosomal dominant Alzheimer disease: The third most cited paper titled, “Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease,” was published in 2020 in Nature Medicine and received 597 citations (Zhou et al., 2020).